PACIRA BIOSCIENCES IN

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

09 Jul 2024 08:45:29 By NetDania Notify

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

02 Jul 2024 08:54:55 By NetDania Notify

Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference

30 May 2024 07:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences, Inc. Announces Pricing of $250.0 Million Aggregate Principal Amount of 2.125% Convertible Senior Notes due 2029

10 May 2024 06:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes

08 May 2024 15:05:14 By Nasdaq GlobeNewswire

Pacira BioSciences Reports First Quarter 2024 Financial Results and Announces $150 Million Share Repurchase program

07 May 2024 15:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference

07 May 2024 07:00:00 By Nasdaq GlobeNewswire

Pacira to Report First Quarter 2024 Financial Results on Tuesday May 7, 2024

30 Apr 2024 07:00:01 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

25 Apr 2024 08:45:09 By NetDania Notify

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

22 Apr 2024 10:49:23 By NetDania Notify

NetDania - New 12 months Low: PACIRA BIOSCIENCES INC. - COMMON STOCK

15 Apr 2024 10:02:15 By NetDania Notify

Pacira BioSciences to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

02 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Announces PCRX-201 Granted Regenerative Medicine Advance Therapy (RMAT) Designation for the Treatment of Osteoarthritis of the Knee

13 Mar 2024 06:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference

06 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results

29 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Pacira to Report 2023 Financial Results on Thursday February 29, 2024

22 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Pacira Announces Publication of Pivotal Study of EXPAREL as a Sciatic Nerve Block in the Popliteal Fossa for Patients After Bunionectomy

15 Feb 2024 07:36:16 By Nasdaq GlobeNewswire

Pacira BioSciences Awarded Brand Pharmaceuticals Agreement With Premier, Inc.

07 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues

04 Jan 2024 16:00:41 By Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

03 Jan 2024 07:00:01 By Nasdaq GlobeNewswire